Eucrisa
Atopic Dermatitis in the Specialty World
Therapy for atopic dermatitis (AD), a chronic inflammatory skin disease that usually starts in infancy or early ...
AUGUST 12, 2019
FDA Approves Eucrisa for Atopic Dermatitis
Crisaborole, applied topically twice daily, is a phosphodiesterase-4 (PDE-4) inhibitor.
DECEMBER 15, 2016
Load more